Article History
Accepted: 16 May 2023
First Online: 29 May 2023
Declarations
:
: Arathi Nandyala: none.Tulsi Shah: none.Jessica Ailani:-Stock/stock options: CtrlM (2022)-Editorial Boards/Steering Committee: Medscape, NeurologyLive, Current Pain and Headache (Editor, Unusual Headache Syndromes), SELF magazine (medical editor)-Leadership or fiduciary role in other board society, committee or advocacy group: American Headache Society (unpaid)-Participation on a Data Safety Monitoring Board or Advisory Board: Aeon (migraine) and Gore (migraine)-Consulting fees: Abbvie, Amgen, Axsome, Biohaven, BioDeliveryScientificInternational (2022), Eli-Lilly, GlaxoSmithKline, Lundbeck, Linpharma, Impel, Miravio, Pfizer, Neurolief, Neso, Satsuma, Theranica, Teva-Grants or contracts from any entity: Clinical Trials (Grant to institution)—Abbvie (2021), Biohaven (2021), Eli-Lilly (2021), Satsuma (2022), Zosano (2021)
: This article does not contain any studies with human or animal subjects performed by any of the authors.